ICAM-1 and VCAM-1 antisense oligonucleotides attenuate in vivo leucocyte adherence and inflammation in rat inflammatory bowel disease

Gut

Volumn 51, Issue 4, 2002, Pages 529-535

  Rijcken, E ^a   Krieglstein, C F ^a   Anthoni, C ^a   Laukoetter, M G ^a   Mennigen, R ^a   Spiegel, H U ^a   Senninger, N ^a   Bennett, C F ^b   Schuermann, G ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; INDOMETACIN; INTERCELLULAR ADHESION MOLECULE 1; ISIS 17470; ISIS 18155; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENTERITIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE ADHERENCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL ADHESION; ILEITIS; INDOMETHACIN; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; MALE; OLIGONUCLEOTIDES, ANTISENSE; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0036786219     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.51.4.529     Document Type: Article

References (42)

1. Dustin ML, Springer TA. Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu Rev Immunol 1991;9:27-66.
2. Shimizu Y, Newman W, Tanaka Y, et al. Lymphocyte interactions with endothelial cells. Immunol Today 1992;13:106-12.
3. Panés J, Granger DN. Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease. Gastroenterology 1998;114:1066-90.
4. Myers CL, Wertheimer SJ, Schembri-King J, et al. Induction of ICAM-1 by TNF-α, IL-1β, and LPS in human endothelial cells after downregulation of PKC. Am J Physiol 1992;263:C767-72.
5. Haraldsen G, Kvale D, Lien B, et al. Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human intestinal microvascular endothelial cells. J Immunol 1996;156:2558-65.
6. Anderson DC. The role of β2 integrins and intercellular adhesion molecule type 1 in inflammation. In: Granger DN, Schmid-Schoenbein GW, eds. Physiology and pathophysiology of leukocyte adhesion. New York: Oxford University Press, 1995:3-42.
7. Kubes P, Niu XF, Smith CW, et al. A novel beta 1-dependent adhesion pathway on neutrophils: a mechanism invoked by dihydrocytochalasin B or endothelial transmigration. FASEB J 1995;9:1103-11.
8. Henderson RB, Lim LHK, Tessier PA, et al. The use of lymphocyte function-associated antigen (LFA)-1-deficient mice to determine the role of LFA-1, Mac-1, and α4 integrin in the inflammatory response of neutrophils. J Exp Med 2001;194:219-26.
9. Johnston B, Kubes P. The α4-integrin: an alternative pathway for neutrophil recruitement? Immunol Today 1999;20:545-50.
10. Ibbotson GC, Doig C, Kaur J, et al. Functional α4-integrin: a newly identified pathway of neutrophil recruitement in critically ill septic patients. Nat Med 2001;7:465-470.
11. Malizia G, Calabrese A, Cottone M, et al. Expression of leukocyte adhesion molecules by mononuclear phagocytes in inflammatory bowel disease. Gastroenterology 1991;100:150-9.
12. Nakamura S, Ohtani H, Watanabe Y, et al. In situ expression of the cell adhesion molecules in inflammatory bowel disease. Lab Invest 1993;69:77-85.
13. Bernstein CN, Sargent M, Gallatin WM. β2 Integrin/ICAM expression in Crohn's disease. Clin Immunol Immunopathol 1998;86:147-60.
14. Jones SC, Banks RE, Haidar A, et al. Adhesion molecules in inflammatory bowel disease. Gut 1995;36:724-30.
15. Göke M, Hoffmann JC, Evers J, et al. Elevated serum concentrations of soluble selectin and immunoglobulin type adhesion molecules in patients with inflammatory bowel disease. J Gastroenterol 1997;32:480-6.
16. Oshitani N, Campbell A, Bloom S, et al. Adhesion molecule expression on vascular endothelium and nitroblue tetrazolium reducing activity in human colonic mucosa. Scand J Gastroenterol 1995;30:915-20.
17. Koizumi M, King N, Lobb R, et al. Expression of vascular adhesion molecules in inflammatory bowel disease. Gastroenterology 1992;103:840-7.
18. Henninger DD, Panés J, Eppihimer M, et al. Cytokine induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol 1997;158:1825-32.
19. Sans M, Panés J, Ardite E, et al. VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis. Gastroenterology 1999;116:874-83.
20. Crooke ST. Therapeutic applications of oligonucleiotides. Biotechnology (NY) 1992;10:882-6.
21. Bennett CF, Condon TP, Grimm S, et al. Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides. J Immunol 1994;152:3530-40.
22. Hartmann G, Bidlingmaier M, Eigler A, et al. Cytokines and therapeutic oligonucleotides. Cytokines Cell Mol Ther 1997;3:247-56.
23. Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, et al. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med 1996;2:998-1004.
24. Bennett CF, Kornbrust D, Henry S, et al. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. J Pharmacol Exp Ther 1997;280:988-1000.
25. Yacyshyn BR, Bowen-Yacyshyn MB, Jewell L, et al. A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease. Gastroenterology 1998;114:1133-42.
26. Baker BF, Lot SS, Condon TP, et al. 2′-O-(2-methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J Biol Chem 1997;272:11994-2000.
27. Glover JM, Leeds JM, Mant TGK, et al. Phase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302). J Pharmacol Exp Ther 1997;282:1173-80.
28. Yamada T, Deitch E, Specian RD, et al. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 1993;17:641-62.
29. Gonzalez AP, Sepulveda S, Massberg S, et al. In vivo fluorescence microscopy for the assessment of microvascular reperfusion injury in small bowel transplants in rats. Transplantation 1994;58:403-8.
30. M-MAC-1) and anti-CD54 (ICAM-1) monoclonal antibodies on indomethacin induced chronic ileitis in rats. Int J Colorectal Dis 1999;14:219-23.
31. Vilaseca J, Salas A, Guarner F, et al. Participation of thromboxane and other eicosanoids synthesis in the course of experimental inflammatory colitis. Gastroenterology 1990;98:269-77.
32. Nygard G, Anthony A, Piasecki C, et al. Acute indomethacin-induced jejunal injury in the rat: early morphological and biochemical changes. Gastroenterology 1994;106:567-75.
33. Krieglstein CF, Salter JW, Cerwinka WH, et al. Role of intercellular adhesion molecule 1 in indomethacin induced ileitis. Biochem Biophys Res Commun 2001;282:635-42.
34. Kelly DA, Piasecki C, Anthony A, et al. Focal reduction of villuos blood flow in early indomethacin enteropathy: adynamic vascular study in the rat. Gut 1998;42:366-73.
35. Taniguchi T, Tsukada H, Nakamura H, et al. Effects of the anti-ICAM-1 monoclonal antibody on dextran sodium sulphate-induced colitis in rats. J Gastroenterol Hepatol 1998;13:945-9.
36. Soriano A, Salas A, Salas A, et al. VCAM-1, but not ICAM-1 or MAdCAM-1, immunoblockade ameliorates DSS-induced colitis in mice. Lab Invest 2000;80:1541-51.
37. Steeber DA, Campbell MA, Basit A, et al. Optimal selectin-mediated rolling of leukoyctes during inflammation in vivo requires intercellular adhesion molecule-1 expression. Proc Natl Acad Sci U S A 1998;95:7562-7.
38. Ramos CL, Huo Y, Jung U, et al. Direct demonstration of P-selectin and VCAM-1-dependent mononuclear cell rolling in early artherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res 1999;84:1237-44.
39. Schuermann G, Aber-Bishop AE, Facer P, et al. Altered expression of cell adhesion molecules in uninvolved gut in inflammatory bowel disease. Clin Exp Immunol 1993;94:341-7.
40. Gordon FH, Lai CWY, Hamilton MI, et al. A randomized placebo-controlled trial of a humanized monoclonal antibody to α4 integrin in active crohn's disease. Gastroenterology 2001;121:268-74.
41. Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995;108:1617-21.
42. Sandborn WJ, Hanauer SB. Anti-tumor necrosis factor therapy for inflammatory bowel disease: a review of agents pharmacology, clinical results, and safety. Inflamm Bowel Dis 1999;5:119-33.